Avandia Retaining Preferred Status On 2008 Part D Formularies – For Now
Executive Summary
So far GlaxoSmithKline's Avandia (rosiglitazone) appears to be retaining its tier 2 status on the 2008 formularies of major Medicare Part D plans despite safety concerns that surfaced earlier this year